Anzeige
Meldung des Tages: Technisches Qualitätssiegel: Diese Kupfer-News liefert Substanz – und genau das macht sie jetzt spannend

Trend Innovations Holding Aktie News

Aktie
WKN:  ISIN:  US89487B1008 US-Symbol:  AVAI
0,4 $
+0,0028 $
+0,70%
0,33948 € 23.02.26
Depot/Watchlist
Marktkapitalisierung *
-
Streubesitz
-
KGV
-
Index-Zuordnung
-

Trend Innovations Holding News

11.02.26 - PR Newswire
Avant Technologies Completes Rebranding with Name Change to Avaí Bio and Launch of New Website
Avant Technologies Completes Rebranding with Name Change to Avaí Bio and Launch of New Website PR Newswire
29.01.26 - PR Newswire
Longevity Biotech Stocks Surge as $27 Trillion Healthcare Shift Favors Cell Restoration
Longevity Biotech Stocks Surge as $27 Trillion Healthcare Shift Favors Cell Restoration PR Newswire
26.01.26 - PR Newswire
Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets
Breaking Barriers: How 2026's Top Clinical Leaders Are Disrupting Chronic Disease Markets PR Newswire
26.01.26 - PR Newswire
Avant Technologies Evaluating Advanced Cells for Diabetes Therapy at 15th Annual EPITA Symposium
Avant Technologies Evaluating Advanced Cells for Diabetes Therapy at 15th Annual EPITA Symposium PR Newswire
02.01.26 - PR Newswire
Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize
Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize PR Newswire
31.12.25 - PR Newswire
The End of Shots? 5 Biotech Stocks Rethinking Diabetes
The End of Shots? 5 Biotech Stocks Rethinking Diabetes PR Newswire
16.12.25 - PR Newswire
Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy
Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy PR Newswire
16.12.25 - PR Newswire
Avant Technologies Highlights the Critical Role of Cell Encapsulation Technology in Revolutionizing Diabetes Treatment
Avant Technologies Highlights the Critical Role of Cell Encapsulation Technology in Revolutionizing Diabetes Treatment PR Newswire
09.12.25 - PR Newswire
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
Beyond Traditional Drugs: Novel Platforms Targeting Hard-​to-Treat Conditions PR Newswire
09.12.25 - PR Newswire
Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular Survival
Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular Survival PR Newswire
21.10.25 - PR Newswire
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
Beyond Traditional Drugs: Novel Platforms Targeting Hard-​to-Treat Conditions PR Newswire
21.10.25 - PR Newswire
Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions
Beyond Traditional Drugs: Novel Platforms Targeting Hard-​to-Treat Conditions PR Newswire
21.10.25 - PR Newswire
Avant Technologies and Austrianova Launch Klothonova, Begin Developing Age Related Cellular Therapies Using 'Longevity Protein' Klotho
Avant Technologies and Austrianova Launch Klothonova, Begin Developing Age Related Cellular Therapies Using 'Longevity Protein' Klotho PR Newswire
25.09.25 - PR Newswire
Healthcare Innovation Accelerates as Four Converging Forces Drive Early Intervention Focus
Healthcare Innovation Accelerates as Four Converging Forces Drive Early Intervention Focus PR Newswire
25.09.25 - PR Newswire
Healthcare Innovation Accelerates as Four Converging Forces Drive Early Intervention Focus
Healthcare Innovation Accelerates as Four Converging Forces Drive Early Intervention Focus PR Newswire
25.09.25 - PR Newswire
Avant Technologies, Inc. Bolsters Strategic Vision with Targeted Biotech Partnerships for Innovative Cell-Based Therapies
Avant Technologies, Inc. Bolsters Strategic Vision with Targeted Biotech Partnerships for Innovative Cell-​Based Therapies PR Newswire
24.09.25 - PR Newswire
Avant Technologies, Inc. Issues Retraction of September 24, 2025 Press Release
Avant Technologies, Inc. Issues Retraction of September 24, 2025 Press Release PR Newswire
24.09.25 - PR Newswire
/DISREGARD RELEASE: Avant Technologies Inc./
/DISREGARD RELEASE: Avant Technologies Inc./ PR Newswire
18.09.25 - PR Newswire
Anti-Aging Biotech Surges as $101M Competition Ignites Global Race Against Aging Demographics
Anti-​Aging Biotech Surges as $101M Competition Ignites Global Race Against Aging Demographics PR Newswire
18.09.25 - PR Newswire
Anti-Aging Biotech Surges as $101M Competition Ignites Global Race Against Aging Demographics
Anti-​Aging Biotech Surges as $101M Competition Ignites Global Race Against Aging Demographics PR Newswire

Newssuche

Videos

newspaper
18.02.26 -4,22%
Technical Trading: Chance mit 82 Prozent Treffern
Rohöl Long Typ: Turbo Open End WKN: VH65XQ Hebel:6 Laufzeit: OpenEnd Einstieg: Market ... Mehr »